Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
BEAM Insider Trading and Fund Holdings (Beam Therapeutics Inc.) · https://wallstpal.com/stock/beam/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 1745999

Beam Therapeutics Inc. (BEAM): Insider Trades and Fund Holdings

In the past 12 months, Beam Therapeutics Inc. insiders reported no open-market purchases and 9 sales worth $13.4M; 7 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$13.4MSold by insiders, 12 months
2Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Oct 16, 2026Insider saleCEO John M. Evans sold $599,595 under a 10b5-1 plan
  2. Oct 16, 2026Planned saleJOHN M EVANS (officer, director) filed notice to sell about $599,595 around Oct 16, 2026
  3. Oct 15, 2026Insider saleCEO John M. Evans sold $589,150 under a 10b5-1 plan
  4. Oct 15, 2026Planned saleJOHN M EVANS (officer, director) filed notice to sell about $589,150 around Oct 15, 2026
  5. Oct 1, 2026Insider saleSVP Bethany J. Cavanagh sold $4,565 under a 10b5-1 plan
  6. Aug 4, 2026NewsCompany reported: Quarterly or annual results
  7. Jul 27, 2026Insider saleChief Medical Officer Amy Simon sold $429,037 under a 10b5-1 plan
  8. Jun 30, 2026Insider saleChief Medical Officer Amy Simon sold $12,954 under a 10b5-1 plan
  9. Jun 30, 2026Insider saleCEO John M. Evans sold $857,685 under a 10b5-1 plan
  10. Jun 30, 2026FundDuquesne Family Office opened a position in Q2 2026 (13F filed Aug 14, 2026)
  11. Jun 30, 2026FundRenaissance Technologies cut 13% in Q2 2026 (13F filed Aug 13, 2026)
  12. Jun 29, 2026Insider saleCEO John M. Evans sold $887,352 under a 10b5-1 plan
  13. Jun 26, 2026Insider sale10% owner Fmr LLC sold $8.9 million
  14. Jun 25, 2026Insider sale10% owner Fmr LLC sold $1.2 million

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 16, 2026.

Recent BEAM insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Oct 16Oct 16John M. EvansCEOCEO▼ SELL10b5-125,00023.98$600K−2.3%Form 4 ↗
Oct 16Oct 15John M. EvansCEOCEO▼ SELL10b5-125,00023.57$589K−2.3%Form 4 ↗
Oct 2Oct 1Bethany J. CavanaghSVPSVP▼ SELL10b5-118724.41$5K−0.4%Form 4 ↗
Jul 29Jul 27Amy SimonChief Medical OfficerChief Medical Officer▼ SELL10b5-116,66725.74$429K−16%Form 4 ↗
Jul 2Jun 30Amy SimonChief Medical OfficerChief Medical Officer▼ SELL10b5-137334.73$13K−0.4%Form 4 ↗
Jul 1Jun 29John M. EvansCEOCEO▼ SELL10b5-125,00035.49$887K−2.3%Form 4 ↗
Jul 1Jun 30John M. EvansCEOCEO▼ SELL10b5-125,00034.31$858K−2.3%Form 4 ↗
Jun 29Jun 26Fmr LLC10% owner10% owner (ind.)▼ SELL251,48835.26$8.87M−23%Form 4 ↗
Jun 29Jun 25Fmr LLC10% owner10% owner (ind.)▼ SELL33,37235.12$1.17M−2.9%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
John M. EvansCEO0$04$2.93MOct 16, 2026
Bethany J. CavanaghSVP0$01$5KOct 2, 2026
Amy SimonChief Medical Officer0$02$442KJul 29, 2026
Fmr LLC10% owner0$02$10.0MJun 29, 2026

Buybacks and executive pay

YearCEO pay reportedCEO pay "actually paid"Value of $100 invested
2025$5.82M$8.40Mn/a
2024$6.41M$7.27Mn/a
2023$6.28M$2.83Mn/a

From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.

Filing quality

A All 9 insider trades reported on time. How it is graded

Tracked funds that report BEAM

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Renaissance TechnologiesQ2 2026445,000$15.3M0.02%▼ −13.4%
Duquesne Family OfficeQ2 2026153,600$5K0.12%▲ New
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →